Loading…

High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges

Analysis and interpretation of Ig and TCR gene rearrangements in the conventional, low-throughput way have their limitations in terms of resolution, coverage, and biases. With the advent of high-throughput, next-generation sequencing (NGS) technologies, a deeper analysis of Ig and/or TCR (IG/TR) gen...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of immunology (1950) 2017-05, Vol.198 (10), p.3765-3774
Main Authors: Langerak, Anton W, Brüggemann, Monika, Davi, Frédéric, Darzentas, Nikos, van Dongen, Jacques J M, Gonzalez, David, Cazzaniga, Gianni, Giudicelli, Véronique, Lefranc, Marie-Paule, Giraud, Mathieu, Macintyre, Elizabeth A, Hummel, Michael, Pott, Christiane, Groenen, Patricia J T A, Stamatopoulos, Kostas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Analysis and interpretation of Ig and TCR gene rearrangements in the conventional, low-throughput way have their limitations in terms of resolution, coverage, and biases. With the advent of high-throughput, next-generation sequencing (NGS) technologies, a deeper analysis of Ig and/or TCR (IG/TR) gene rearrangements is now within reach, which impacts on all main applications of IG/TR immunogenetic analysis. To bridge the generation gap from low- to high-throughput analysis, the EuroClonality-NGS Consortium has been formed, with the main objectives to develop, standardize, and validate the entire workflow of IG/TR NGS assays for 1) clonality assessment, 2) minimal residual disease detection, and 3) repertoire analysis. This concerns the preanalytical (sample preparation, target choice), analytical (amplification, NGS), and postanalytical (immunoinformatics) phases. Here we critically discuss pitfalls and challenges of IG/TR NGS methodology and its applications in hemato-oncology and immunology.
ISSN:0022-1767
1550-6606
DOI:10.4049/jimmunol.1602050